+Search query
-Structure paper
Title | Development of a low-seroprevalence, alpha v beta 6 integrin-selective virotherapy based on human adenovirus type 10. |
---|---|
Journal, issue, pages | Mol Ther Oncolytics, Vol. 25, Page 43-56, Year 2022 |
Publish date | Feb 14, 2019 (structure data deposition date) |
Authors | Bates, E.A. / Davies, J.A. / Vanova, J. / Nestic, D. / Meniel, V.S. / Koushyar, S. / Cunliffe, T.G. / Mundy, R.M. / Moses, E. / Uusi-Kerttula, H.K. ...Bates, E.A. / Davies, J.A. / Vanova, J. / Nestic, D. / Meniel, V.S. / Koushyar, S. / Cunliffe, T.G. / Mundy, R.M. / Moses, E. / Uusi-Kerttula, H.K. / Baker, A.T. / Cole, D.K. / Majhen, D. / Rizkallah, P.J. / Phesse, T. / Chester, J.D. / Parker, A.L. |
External links | Mol Ther Oncolytics / PubMed:35399606 |
Methods | X-ray diffraction |
Resolution | 2.5 - 3.39 Å |
Structure data | PDB-6qpm: PDB-6zc5: |
Source |
|
Keywords | VIRAL PROTEIN / Adenovirus / AdV / HAdV / HAdV-D10 / Ad10 / serotype 10 / Fiber / Fiber-knob / Fibre / knob domain / head / pIV / protein IV / Adenoviridae |